๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

โœ Scribed by Bejarano, Victoria ;Quinn, Mark ;Conaghan, Philip G. ;Reece, Richard ;Keenan, Anne-Maree ;Walker, David ;Gough, Andrew ;Green, Michael ;McGonagle, Dennis ;Adebajo, Ade ;Jarrett, Stephen ;Doherty, Sheelagh ;Hordon, Lesley ;Melsom, Richard ;Unnebrink, Kristina ;Kupper, Hartmut ;Emery, Paul ;,


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
155 KB
Volume
59
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment with tumor necrosis factor inh
โœ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt Rantapรครค-Dahlqvist; Jo ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 1 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (antiโ€TNF) are conflicting in patients

Early effects of rituximab on the synovi
โœ Koen Vos; Rogier M. Thurlings; Carla A. Wijbrandts; Dirkjan van Schaardenburg; D ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 202 KB ๐Ÿ‘ 1 views

## Abstract ## Objective To study the specific effects of rituximab treatment on the synovium in patients with rheumatoid arthritis (RA) early after initiation of treatment. ## Methods Seventeen RA patients underwent an arthroscopic synovial biopsy procedure directly before and 1 month after rec

Lymphoma in rheumatoid arthritis: The ef
โœ Frederick Wolfe; Kaleb Michaud ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 118 KB ๐Ÿ‘ 1 views

## Abstract ## Objective The risk of lymphoma is increased in patients with rheumatoid arthritis (RA), and spontaneous reporting suggests that methotrexate (MTX) and antiโ€“tumor necrosis factor (antiโ€TNF) therapy might be associated independently with an increased risk of lymphoma. However, data fr